Kevin Nash, PhD

Dr. Nash has over 20 years of research experience spanning biochemistry, molecular biology, and neuroscience. He is a recognized expert in adeno-associated virus (AAV) biology and its application in neurodegenerative and neurodevelopmental disease models. His work has revealed novel mechanisms of immune regulation in Alzheimer’s and Parkinson’s disease, including the dual anti- and pro-inflammatory actions of fractalkine (CX3CL1) on microglia. In Angelman syndrome research, Dr. Nash’s lab pioneered AAV-mediated gene therapy approaches, demonstrating cognitive and electrophysiological rescue in rodent models using secreted UBE3A. His team is also investigating therapeutic roles of Reelin and its fragments in schizophrenia and Fragile X models.

As Graduate Coordinator for the Neuroscience program at USF, Dr. Nash oversees student training and progression, serving on more than 40 graduate committees. He has mentored numerous graduate, postdoctoral, and undergraduate researchers, many of whom have advanced to medical or graduate programs. Dr. Nash is deeply committed to fostering critical thinking and scientific independence in his trainees.